Stocks and Investing Stocks and Investing
Tue, July 6, 2021
Mon, July 5, 2021
Fri, July 2, 2021
Thu, July 1, 2021

Danielle Brill Initiated (VRTX) at Hold on, Jul 1st, 2021


Published on 2024-10-27 17:06:29 - WOPRAI, Danielle Brill
  Print publication without navigation


Danielle Brill of Raymond James, Initiated "Vertex Pharmaceuticals Incorporated" (VRTX) at Hold on, Jul 1st, 2021.

Danielle has made no other calls on VRTX in the last 4 months.



There are 13 other peers that have a rating on VRTX. Out of the 13 peers that are also analyzing VRTX, 2 agree with Danielle's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Geoffrey Porges of "SVB Leerink" Maintained at Hold with Decreased Target to $200 on, Monday, June 14th, 2021
  • Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $205 on, Friday, June 11th, 2021


These are the ratings of the 11 analyists that currently disagree with Danielle


  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $261 on, Monday, June 14th, 2021
  • Robyn Karnauskas of "Truist Securities" Maintained at Strong Buy with Increased Target to $331 on, Monday, June 14th, 2021
  • Salveen Richter of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $307 on, Friday, June 11th, 2021
  • Mohit Bansal of "Citigroup" Maintained at Strong Buy with Decreased Target to $285 on, Friday, June 11th, 2021
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Decreased Target to $244 on, Friday, June 11th, 2021
  • Gena Wang of "Barclays" Maintained at Buy with Decreased Target to $285 on, Friday, June 11th, 2021
  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Decreased Target to $281 on, Friday, June 11th, 2021
  • Brian Abrahams of "RBC Capital" Maintained at Buy with Decreased Target to $242 on, Friday, June 11th, 2021
  • Brian Skorney of "Baird" Maintained at Buy with Decreased Target to $240 on, Friday, June 11th, 2021
  • Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $279 on, Wednesday, May 12th, 2021
  • Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $260 on, Monday, May 3rd, 2021

Contributing Sources